- Home
- PDS vs BCYC Comparison
PDS vs BCYC Comparison
Compare PDS & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDS
- BCYC
- Stock Information
- Founded
- PDS 1951
- BCYC 2009
- Country
- PDS Canada
- BCYC United Kingdom
- Employees
- PDS N/A
- BCYC N/A
- Industry
- PDS
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- PDS
- BCYC Health Care
- Exchange
- PDS Nasdaq
- BCYC Nasdaq
- Market Cap
- PDS 872.2M
- BCYC 896.2M
- IPO Year
- PDS N/A
- BCYC 2019
- Fundamental
- Price
- PDS $58.29
- BCYC $12.89
- Analyst Decision
- PDS Buy
- BCYC Buy
- Analyst Count
- PDS 1
- BCYC 9
- Target Price
- PDS $95.00
- BCYC $33.25
- AVG Volume (30 Days)
- PDS 76.9K
- BCYC 357.8K
- Earning Date
- PDS 02-12-2025
- BCYC 02-18-2025
- Dividend Yield
- PDS N/A
- BCYC N/A
- EPS Growth
- PDS 62.11
- BCYC N/A
- EPS
- PDS 12.37
- BCYC N/A
- Revenue
- PDS $1,436,787,445.00
- BCYC $36,898,000.00
- Revenue This Year
- PDS $2.38
- BCYC $41.07
- Revenue Next Year
- PDS $2.42
- BCYC N/A
- P/E Ratio
- PDS $4.71
- BCYC N/A
- Revenue Growth
- PDS N/A
- BCYC 48.60
- 52 Week Low
- PDS $54.49
- BCYC $12.17
- 52 Week High
- PDS $79.07
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- PDS 30.72
- BCYC 38.19
- Support Level
- PDS $59.06
- BCYC $12.45
- Resistance Level
- PDS $61.37
- BCYC $13.63
- Average True Range (ATR)
- PDS 1.95
- BCYC 0.77
- MACD
- PDS -0.99
- BCYC 0.13
- Stochastic Oscillator
- PDS 8.09
- BCYC 15.44
About PDS Precision Drilling Corporation
Precision Drilling Corpd is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.